Federated Hermes’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-45
| Closed | -$1.3K | – | 2214 |
|
2024
Q4 | $1.3K | Buy |
+45
| New | +$1.3K | ﹤0.01% | 2005 |
|
2023
Q3 | – | Sell |
-58,308
| Closed | -$1.06M | – | 2215 |
|
2023
Q2 | $1.06M | Sell |
58,308
-258
| -0.4% | -$4.7K | ﹤0.01% | 1122 |
|
2023
Q1 | $1M | Sell |
58,566
-92,648
| -61% | -$1.59M | ﹤0.01% | 1166 |
|
2022
Q4 | $3.51M | Buy |
151,214
+74
| +0% | +$1.72K | 0.01% | 757 |
|
2022
Q3 | $3.35M | Buy |
151,140
+239
| +0.2% | +$5.3K | 0.01% | 763 |
|
2022
Q2 | $2.91M | Hold |
150,901
| – | – | 0.01% | 830 |
|
2022
Q1 | $5.39M | Hold |
150,901
| – | – | 0.01% | 763 |
|
2021
Q4 | $13.1M | Hold |
150,901
| – | – | 0.02% | 582 |
|
2021
Q3 | $17.3M | Buy |
150,901
+58,044
| +63% | +$6.66M | 0.03% | 511 |
|
2021
Q2 | $20M | Buy |
+92,857
| New | +$20M | 0.04% | 481 |
|